This guide breaks down how to prepare for an HS appointment so your treatment plan reflects more than just today's flare.

Hidradenitis suppurativa is a debilitating, chronic inflammatory disorder where physical examination often fails to capture ...

Dermatologists say managing HS-prone skin isn't about harsh products or over-cleansing-it's about reducing irritation and ...

Reproductive-care access remains unsettled as mifepristone telehealth/mail distribution is temporarily protected by the ...

The use of GLP-1 RAs may be appropriate among select patients with psoriasis, although additional research is needed to guide ...

Two months after UCB revealed the success of Bimzelx in a head-to-head trial against AbbVie’s Skyrizi in patients with psoriatic arthritis (PsA), the Belgian drugmaker has unveiled the detailed ...

Detailed price information for Monte Rosa Therapeutics Inc (GLUE-Q) from The Globe and Mail including charting and trades.

UCB, a global biopharmaceutical company, today announced Week 16 data from the BE BOLD trial demonstrating superior ACR50 joint outcomes at Week 16 for BIMZELX® (bimekizumab-bkzx) versus SKYRIZI® ...

There’s nothing more alarming than finding out your skin has a case of mistaken identity. You go years convinced you have ...

Dragonfly Therapeutics, a clinical-stage biopharmaceutical company pioneering novel immunotherapies, today announced that the first patients have been successfully dosed subcutaneously (SC) with its ...